Besides inhibitory cytokines and depleted metabolic factors, the inhibitory checkpoint PD-1/PD-L1 axis reduces T-cell infiltration and negatively influences efficacy, fitness, and persistence of TCR-Ts in many types of cancer. This evidence concerns the gene CD274 and cancer.